Skip to main content
Erschienen in: International Orthopaedics 3/2006

01.06.2006 | Original Paper

Changes in coagulation and fibrinolysis of post-SARS osteonecrosis in a Chinese population

verfasst von: Wei Sun, Zi–rong Li, Zhen–cai Shi, Nian–fei Zhang, Yuan–chun Zhang

Erschienen in: International Orthopaedics | Ausgabe 3/2006

Einloggen, um Zugang zu erhalten

Abstract

The purpose of this study was to detect changes in coagulation and fibrinolysis of post-severe acute respiratory syndrome (SARS) Chinese patients with osteonecrosis, investigate the aetiology of post-SARS osteonecrosis (ON), and select the sensitive molecular markers for identifying the susceptible population. For this study, blood samples were collected from 88 patients with post-SARS ON and 52 healthy people. Activated partial thromboplastin time (APTT), protein C (PC), antithrombin III (AT–III), plasminogen activator inhibitor (PAI), activated protein C resistance (APC–R), plasminogen (PLG), von Willebrand’s factor(vWF), D–dimer (D–D), fibrinogen (Fib), and homocysteine (HCY) were examined by enzyme-linked immunosorbent assay (ELISA). We noted that blood agents of patients with ON changed obviously. APTT, PC, AT–III, PAI, APC–R, and PLG were significantly different between the two groups. Hypercoagulation and hypofibrinolysis were found in patients with post-SARS ON. Therefore, these examinations can be used to screen a population susceptible to ON. Measurements of APTT, PC, AT–III, PAI, APC–R, and PLG are sensitive blood tests for screening purposes.
Literatur
1.
Zurück zum Zitat Jones JP Jr (1992) Intravascular coagulation and osteonecrosis. Clin Orthop 277:41–53PubMed Jones JP Jr (1992) Intravascular coagulation and osteonecrosis. Clin Orthop 277:41–53PubMed
2.
Zurück zum Zitat Miller KD, Masur H, Jones EC et al (2002) High prevalence of osteonecrosis of the femoral head in HIV-infected adults. Ann Intern Med 137:17–25PubMed Miller KD, Masur H, Jones EC et al (2002) High prevalence of osteonecrosis of the femoral head in HIV-infected adults. Ann Intern Med 137:17–25PubMed
3.
Zurück zum Zitat Bottaro EG, Figueroa RH, Scapellato PG et al (2004) Osteonecrosis in HIV-infected patients. Medicina (B Aires) 64(4):325–331 Bottaro EG, Figueroa RH, Scapellato PG et al (2004) Osteonecrosis in HIV-infected patients. Medicina (B Aires) 64(4):325–331
4.
Zurück zum Zitat Jones JP Jr, Sakovich L, Anderson CE (1974) Experimentally produced osteonecrosis as a result of fat embolism. In: Beckman EL, Elliott DH, Smith EM (eds) Dysbarism-Related Osteonecrosis. HEW Publ (NIOSH) 75–153, Washington, DC, U.S. Government Printing Office, p 117 Jones JP Jr, Sakovich L, Anderson CE (1974) Experimentally produced osteonecrosis as a result of fat embolism. In: Beckman EL, Elliott DH, Smith EM (eds) Dysbarism-Related Osteonecrosis. HEW Publ (NIOSH) 75–153, Washington, DC, U.S. Government Printing Office, p 117
5.
Zurück zum Zitat Jones JP Jr (1994) Concepts of etiology and early pathogenesis of osteonecrosis. In: Schafer M (ed) Instructional course lectures 43. American Academy of Orthopaedic Surgeons, Rosemont, IL, p 499 Jones JP Jr (1994) Concepts of etiology and early pathogenesis of osteonecrosis. In: Schafer M (ed) Instructional course lectures 43. American Academy of Orthopaedic Surgeons, Rosemont, IL, p 499
6.
Zurück zum Zitat Starklint H, Lausten CS, Arnoldi CC (1995) Microvascular obstruction in avascular necrosis: immunohistochemistry of 14 femoral heads. Acta Orthop Scand 66:9–12PubMed Starklint H, Lausten CS, Arnoldi CC (1995) Microvascular obstruction in avascular necrosis: immunohistochemistry of 14 femoral heads. Acta Orthop Scand 66:9–12PubMed
7.
Zurück zum Zitat Jones JP (1997) Risk factors potentially activating intravascular coagulation and causing nontraumatic osteonecrosis. In: Urbaniak JR, Jones JP Jr (eds) Osteonecrosis: etiology, diagnosis, and treatment. American Academy of Orthopaedic Surgeons, Rosemont, IL, p 89 Jones JP (1997) Risk factors potentially activating intravascular coagulation and causing nontraumatic osteonecrosis. In: Urbaniak JR, Jones JP Jr (eds) Osteonecrosis: etiology, diagnosis, and treatment. American Academy of Orthopaedic Surgeons, Rosemont, IL, p 89
8.
Zurück zum Zitat Jones LC, Mont MA, Le TB et al (2003) Procoagulants and Osteonecrosis. J Rheumatol 30:783–791PubMed Jones LC, Mont MA, Le TB et al (2003) Procoagulants and Osteonecrosis. J Rheumatol 30:783–791PubMed
9.
Zurück zum Zitat Glueck CJ, Freiberg RA, Wang P (2003) Role of thrombosis in osteonecrosis. Curr Hematol Rep 2:417–422PubMed Glueck CJ, Freiberg RA, Wang P (2003) Role of thrombosis in osteonecrosis. Curr Hematol Rep 2:417–422PubMed
10.
Zurück zum Zitat Nilsson IM, Krook H, Sternby HH et al (1961) Severe thrombotic disease in a young man with bone marrow and skeletal changes and with a high content of an inhibitor in the fibrinolytic system. Acta Med Scand 169:323–337PubMedCrossRef Nilsson IM, Krook H, Sternby HH et al (1961) Severe thrombotic disease in a young man with bone marrow and skeletal changes and with a high content of an inhibitor in the fibrinolytic system. Acta Med Scand 169:323–337PubMedCrossRef
11.
Zurück zum Zitat Glueck CJ, Glueck HI, Mieczkowski L et al (1993) Familial high plasminogen activator inhibitor with hypofibrinolysis, a new pathophysiologic cause of osteonecrosis? Thromb Haemost 69:460–465PubMed Glueck CJ, Glueck HI, Mieczkowski L et al (1993) Familial high plasminogen activator inhibitor with hypofibrinolysis, a new pathophysiologic cause of osteonecrosis? Thromb Haemost 69:460–465PubMed
12.
Zurück zum Zitat Glueck CJ, Freiberg R, Glueck HI et al (1994) Hypofibrinolysis: a common, major cause of osteonecrosis. Am J Hematol 45:156–166PubMedCrossRef Glueck CJ, Freiberg R, Glueck HI et al (1994) Hypofibrinolysis: a common, major cause of osteonecrosis. Am J Hematol 45:156–166PubMedCrossRef
13.
Zurück zum Zitat Glueck CJ, Freiberg R, Glueck HI et al (1995) Idiopathic osteonecrosis, hypofibrinolysis, high plasminogen activator inhibitor, high lipoprotein (a), and therapy with Stanozolol. Am J Hematol 48:213–220PubMedCrossRef Glueck CJ, Freiberg R, Glueck HI et al (1995) Idiopathic osteonecrosis, hypofibrinolysis, high plasminogen activator inhibitor, high lipoprotein (a), and therapy with Stanozolol. Am J Hematol 48:213–220PubMedCrossRef
14.
Zurück zum Zitat Van Veldhuizen PJ, Neff J, Murphey MD et al (1993) Decreased fibrinolytic potential in patients with idiopathic avascular necrosis and transient osteoporosis of the hip. Am J Hematol 44:243–248PubMedCrossRef Van Veldhuizen PJ, Neff J, Murphey MD et al (1993) Decreased fibrinolytic potential in patients with idiopathic avascular necrosis and transient osteoporosis of the hip. Am J Hematol 44:243–248PubMedCrossRef
15.
Zurück zum Zitat Glueck CJ, Freiberg RA, Fontaine RN et al (2001) Hypofibrinolysis, thrombophilia, osteonecrosis. Clin Orthop 386:19–33PubMedCrossRef Glueck CJ, Freiberg RA, Fontaine RN et al (2001) Hypofibrinolysis, thrombophilia, osteonecrosis. Clin Orthop 386:19–33PubMedCrossRef
16.
Zurück zum Zitat Glueck CJ, Fontaine RN, Gruppo R et al (1999) The plasminogen activator inhibitor–1 gene, hypofibrinolysis, and osteonecrosis. Clin Orthop 366:133–146PubMedCrossRef Glueck CJ, Fontaine RN, Gruppo R et al (1999) The plasminogen activator inhibitor–1 gene, hypofibrinolysis, and osteonecrosis. Clin Orthop 366:133–146PubMedCrossRef
17.
Zurück zum Zitat Glueck CJ, Freiberg R, Tracy T et al (1997) Thrombophilia and hypofibrinolysis: pathophysiologies of osteonecrosis. Clin Orthop 334:43–56PubMed Glueck CJ, Freiberg R, Tracy T et al (1997) Thrombophilia and hypofibrinolysis: pathophysiologies of osteonecrosis. Clin Orthop 334:43–56PubMed
18.
Zurück zum Zitat Jones JP (2000) Epidemiological risk factors for non-traumatic osteonecrosis. Orthopede 29:370–379 Jones JP (2000) Epidemiological risk factors for non-traumatic osteonecrosis. Orthopede 29:370–379
19.
Zurück zum Zitat Korompilias AV, Gilkeson GS, Ortel TL et al (1997) Anticardiolipin antibodies and osteonecrosis of the femoral head. Clin Orthop 345:174–180PubMed Korompilias AV, Gilkeson GS, Ortel TL et al (1997) Anticardiolipin antibodies and osteonecrosis of the femoral head. Clin Orthop 345:174–180PubMed
20.
Zurück zum Zitat Kubo T, Tsuhi H, Yamamoto T et al (2000) Antithrombin III deficiency in a patient with multifocal osteonecrosis. Clin Orthop 378:306–311PubMedCrossRef Kubo T, Tsuhi H, Yamamoto T et al (2000) Antithrombin III deficiency in a patient with multifocal osteonecrosis. Clin Orthop 378:306–311PubMedCrossRef
21.
Zurück zum Zitat Berger CE, Kroner A, Stiegler H et al (2002) Hypofibrinolysis, lipoprotein (a) and plasminogen activator inhibitor. Clin Orthop 397:342–349PubMedCrossRef Berger CE, Kroner A, Stiegler H et al (2002) Hypofibrinolysis, lipoprotein (a) and plasminogen activator inhibitor. Clin Orthop 397:342–349PubMedCrossRef
22.
Zurück zum Zitat Cosgriff SW (1951) Thromboembolic complications associated with ACTH and cortisone therapy. JAMA 147:924–926 Cosgriff SW (1951) Thromboembolic complications associated with ACTH and cortisone therapy. JAMA 147:924–926
23.
Zurück zum Zitat Aaron RK, Ciombor DM (2001) Coagulopathies and osteonecrosis. Curr Opin Orthop 12:378–383CrossRef Aaron RK, Ciombor DM (2001) Coagulopathies and osteonecrosis. Curr Opin Orthop 12:378–383CrossRef
24.
Zurück zum Zitat Bjorkman A, Svensson PJ, Hillarp A et al (2004) Factor V leiden and prothrombin gene mutation: risk factors for osteonecrosis of the femoral head in adults. Clin Orthop 425:168–172PubMedCrossRef Bjorkman A, Svensson PJ, Hillarp A et al (2004) Factor V leiden and prothrombin gene mutation: risk factors for osteonecrosis of the femoral head in adults. Clin Orthop 425:168–172PubMedCrossRef
25.
Zurück zum Zitat Charalampos GZ, Geotge V, Eleni D et al (2004) Genetic background of osteonecrosis: associated with thrombophilic mutations? Clin Orthop 422:251–255CrossRef Charalampos GZ, Geotge V, Eleni D et al (2004) Genetic background of osteonecrosis: associated with thrombophilic mutations? Clin Orthop 422:251–255CrossRef
26.
Zurück zum Zitat Lee JS, Koo KH, Ha YC et al (2003) Role of thrombotic and fibrinolytic disorders in osteonecrosis of the femoral head. Clin Orthop 417:270–276PubMed Lee JS, Koo KH, Ha YC et al (2003) Role of thrombotic and fibrinolytic disorders in osteonecrosis of the femoral head. Clin Orthop 417:270–276PubMed
27.
Zurück zum Zitat Zheng JM, Lu XH, Dong TH et al (2002) The study of hematological change of nontraumatic osteonecrosis of femoral head. Chin J Orthop 22:423–426 Zheng JM, Lu XH, Dong TH et al (2002) The study of hematological change of nontraumatic osteonecrosis of femoral head. Chin J Orthop 22:423–426
28.
Zurück zum Zitat Mont MA, Jones LC, Rajadhyaksha AD et al (2004) Risk factors for pulmonary emboli after total hip or knee arthroplasty. Clin Orthop 422:154–163PubMedCrossRef Mont MA, Jones LC, Rajadhyaksha AD et al (2004) Risk factors for pulmonary emboli after total hip or knee arthroplasty. Clin Orthop 422:154–163PubMedCrossRef
Metadaten
Titel
Changes in coagulation and fibrinolysis of post-SARS osteonecrosis in a Chinese population
verfasst von
Wei Sun
Zi–rong Li
Zhen–cai Shi
Nian–fei Zhang
Yuan–chun Zhang
Publikationsdatum
01.06.2006
Verlag
Springer-Verlag
Erschienen in
International Orthopaedics / Ausgabe 3/2006
Print ISSN: 0341-2695
Elektronische ISSN: 1432-5195
DOI
https://doi.org/10.1007/s00264-005-0067-6

Weitere Artikel der Ausgabe 3/2006

International Orthopaedics 3/2006 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Knie-TEP: Kein Vorteil durch antibiotikahaltigen Knochenzement

29.05.2024 Periprothetische Infektionen Nachrichten

Zur Zementierung einer Knie-TEP wird in Deutschland zu über 98% Knochenzement verwendet, der mit einem Antibiotikum beladen ist. Ob er wirklich besser ist als Zement ohne Antibiotikum, kann laut Registerdaten bezweifelt werden.

Häusliche Gewalt in der orthopädischen Notaufnahme oft nicht erkannt

28.05.2024 Häusliche Gewalt Nachrichten

In der Notaufnahme wird die Chance, Opfer von häuslicher Gewalt zu identifizieren, von Orthopäden und Orthopädinnen offenbar zu wenig genutzt. Darauf deuten die Ergebnisse einer Fragebogenstudie an der Sahlgrenska-Universität in Schweden hin.

Fehlerkultur in der Medizin – Offenheit zählt!

28.05.2024 Fehlerkultur Podcast

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Mehr Frauen im OP – weniger postoperative Komplikationen

21.05.2024 Allgemeine Chirurgie Nachrichten

Ein Frauenanteil von mindestens einem Drittel im ärztlichen Op.-Team war in einer großen retrospektiven Studie aus Kanada mit einer signifikanten Reduktion der postoperativen Morbidität assoziiert.

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.